Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment

Missak Haigentz, Dana M. Hartl, Carl E. Silver, Johannes A. Langendijk, Primoz Strojan, Vinidh Paleri, Remco de Bree, Jean-Pascal Machiels, Marc Hamoir, Alessandra Rinaldo, Daniela Paccagnella, Ashok R. Shaha, Robert P. Takes, Alfio Ferlito*

*Corresponding author for this work

    Research output: Contribution to journalReview articlepeer-review

    47 Citations (Scopus)

    Abstract

    Distant metastases from head and neck squamous cell carcinoma (HNSCC), though rare at initial presentation, remain an important manifestation of cancer recurrence and mortality. Although generally considered incurable with a dismal prognosis despite palliative therapy, highly selected patients with distant metastases may have a long term survival benefit from aggressive surgery or radiotherapy. Advances in systemic treatments also may improve patient survival. This article reviews the current state of management of HNSCC patients with distant metastases. (C) 2012 Elsevier Ltd. All rights reserved.

    Original languageEnglish
    Pages (from-to)787-793
    Number of pages7
    JournalOral Oncology
    Volume48
    Issue number9
    DOIs
    Publication statusPublished - Sept-2012

    Keywords

    • Distant metastases
    • Head and neck squamous cell carcinoma
    • Treatment
    • Chemotherapy
    • Metastasectomy
    • PLATINUM-BASED CHEMOTHERAPY
    • COOPERATIVE-ONCOLOGY-GROUP
    • CISPLATIN PLUS FLUOROURACIL
    • PULMONARY METASTASES
    • PHASE-II
    • RADIOFREQUENCY ABLATION
    • SURGICAL RESECTION
    • LARYNGEAL-CANCER
    • RANDOMIZED-TRIAL
    • SOLID TUMORS

    Fingerprint

    Dive into the research topics of 'Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment'. Together they form a unique fingerprint.

    Cite this